PEKİN, 30 Aralık 2024 /PRNewswire/ — 7 Kasım’da 7. Çin Girişim Forumu’nun Kamu İktisadi Teşebbüslerinin Sosyal Sorumluluğu konulu Paralel Forumu Pekin’de gerçekleştirildi. “Sürdürülebilir Kalkınma için Değer Yaratmak üzere Sosyal Sorumlulukların Yüksek Standartlarla Yerine Getirilmesi”…

SAN DIEGO, Dec. 30, 2024 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that Takeda received regulatory approval for HYQVIA® [Immune Globulin Infusion 10% (Human) with Halozyme’s Recombinant Human Hyaluronidase] by the Japanese Ministry of Health,…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.